{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:01:13Z","timestamp":1791316873066,"version":"4.3.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Startup Fund for Scientific Research,\u00a0Fujian Medical University","award":["2022QH1110"],"award-info":[{"award-number":["2022QH1110"]}]},{"name":"Sanming City Science and Technology Plan Project","award":["2023-S-105"],"award-info":[{"award-number":["2023-S-105"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2024J01665"],"award-info":[{"award-number":["2024J01665"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25463-w","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:32:21Z","timestamp":1763987541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel tumor microenvironment-related gene signature for prognostic prediction of intrahepatic cholangiocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Dongyao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linpei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"2","key":"25463_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bpg.2015.02.002","volume":"29","author":"S Kongpetch","year":"2015","unstructured":"Kongpetch, S. et al. Pathogenesis of cholangiocarcinoma: from genetics to signalling pathways. Best Pract. Res. Clin. Gastroenterol. 29 (2), 233\u2013244 (2015). PubMed PMID: 25966424.","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"10","key":"25463_CR2","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/2159-8290.Cd-17-0368","volume":"7","author":"A Jusakul","year":"2017","unstructured":"Jusakul, A. et al. Whole-Genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma. Cancer Discov. 7 (10), 1116\u20131135. https:\/\/doi.org\/10.1158\/2159-8290.Cd-17-0368 (2017). Epub 20170630.","journal-title":"Cancer Discov"},{"issue":"4","key":"25463_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrgastro","volume":"8","author":"T Patel","year":"2011","unstructured":"Patel, T. Cholangiocarcinoma\u2013controversies and challenges. Nat. Rev. Gastroenterol. Hepatol. 8 (4), 189\u2013200. https:\/\/doi.org\/10.1038\/nrgastro (2011). 2011.20. PubMed PMID: 21460876; PubMed Central PMCID: PMCPMC3888819.","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"25463_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"149","author":"MN Mavros","year":"2014","unstructured":"Mavros, M. N., Economopoulos, K. P., Alexiou, V. G. & Pawlik, T. M. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and Meta-analysis. JAMA Surg. 149 (6), 565\u2013574. https:\/\/doi.org\/10.1001\/jamasurg.2013.5137 (2014).","journal-title":"JAMA Surg."},{"key":"25463_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","volume":"13","author":"K Kourou","year":"2015","unstructured":"Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V. & Fotiadis, D. I. Machine learning applications in cancer prognosis and prediction. Comput. Struct. Biotechnol. J. 13, 8\u201317. https:\/\/doi.org\/10.1016\/j.csbj.2014.11.005 (2015).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"25463_CR6","first-page":"59","volume":"2","author":"JA Cruz","year":"2007","unstructured":"Cruz, J. A. & Wishart, D. S. Applications of machine learning in cancer prediction and prognosis. Cancer Inf. 2, 59\u201377 (2007). Epub 20070211. PubMed PMID: 19458758; PubMed Central PMCID: PMCPMC2675494.","journal-title":"Cancer Inf."},{"issue":"8","key":"25463_CR7","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.cell.2023.01.035","volume":"186","author":"K Swanson","year":"2023","unstructured":"Swanson, K., Wu, E., Zhang, A., Alizadeh, A. A. & Zou, J. From patterns to patients: advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. Cell 186 (8), 1772\u20131791. https:\/\/doi.org\/10.1016\/j.cell.2023.01.035 (2023).","journal-title":"Cell"},{"key":"25463_CR8","doi-asserted-by":"publisher","unstructured":"Zhou, S. N. et al. A New Prognostic Model Covering All Stages of Intrahepatic Cholangiocarcinoma. J Clin Transl Hepatol. ;10(2):254\u2009\u2013\u200962. Epub 20210707. (2022). https:\/\/doi.org\/10.14218\/jcth.2021.00099. PubMed PMID: 35528972; PubMed Central PMCID: PMCPMC9039701.","DOI":"10.14218\/jcth.2021.00099"},{"issue":"1","key":"25463_CR9","doi-asserted-by":"publisher","first-page":"19267","DOI":"10.1038\/s41598-023-45056-9","volume":"13","author":"Y Lv","year":"2023","unstructured":"Lv, Y. et al. A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients. Sci. Rep. 13 (1), 19267. https:\/\/doi.org\/10.1038\/s41598-023-45056-9 (2023).","journal-title":"Sci. Rep."},{"issue":"5","key":"25463_CR10","doi-asserted-by":"publisher","first-page":"e170117","DOI":"10.1001\/jamasurg.2017.0117","volume":"152","author":"M Raoof","year":"2017","unstructured":"Raoof, M. et al. Development and validation of a prognostic score for intrahepatic cholangiocarcinoma. JAMA Surg. 152 (5), e170117\u2013e. https:\/\/doi.org\/10.1001\/jamasurg.2017.0117 (2017).","journal-title":"JAMA Surg."},{"issue":"1","key":"25463_CR11","doi-asserted-by":"publisher","first-page":"22203","DOI":"10.1038\/s41598-024-72790-5","volume":"14","author":"AE Kolasseri","year":"2024","unstructured":"Kolasseri, A. E. Comparative study of machine learning and statistical survival models for enhancing cervical cancer prognosis and risk factor assessment using SEER data. Sci. Rep. 14 (1), 22203. https:\/\/doi.org\/10.1038\/s41598-024-72790-5 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"25463_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hpb.2020.07.007","volume":"23","author":"S B\u00fcttner","year":"2021","unstructured":"B\u00fcttner, S. et al. Quality and performance of validated prognostic models for survival after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. HPB 23 (1), 25\u201336. https:\/\/doi.org\/10.1016\/j.hpb.2020.07.007 (2021).","journal-title":"HPB"},{"issue":"1","key":"25463_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/ehf2.13073","volume":"8","author":"S Shin","year":"2021","unstructured":"Shin, S. et al. Machine learning vs. conventional statistical models for predicting heart failure readmission and mortality. ESC Heart Fail. 8 (1), 106\u2013115. https:\/\/doi.org\/10.1002\/ehf2.13073 (2021). Epub 20201117.","journal-title":"ESC Heart Fail."},{"key":"25463_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2147\/cia.S406735","volume":"18","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Lasso-Based machine learning algorithm for predicting postoperative lung complications in elderly: A Single-Center retrospective study from China. Clin. Interv Aging. 18, 597\u2013606. https:\/\/doi.org\/10.2147\/cia.S406735 (2023). Epub 20230414.","journal-title":"Clin. Interv Aging"},{"issue":"3","key":"25463_CR15","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 41 (3), 374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02 (2023). .016. PubMed PMID: 36917948.","journal-title":"Cancer Cell."},{"issue":"1","key":"25463_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"M-Z Jin","year":"2020","unstructured":"Jin, M-Z. & Jin, W-L. The updated landscape of tumor microenvironment and drug repurposing. Signal. Transduct. Target. Therapy. 5 (1), 166. https:\/\/doi.org\/10.1038\/s41392-020-00280-x (2020).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"25463_CR17","doi-asserted-by":"publisher","first-page":"1037945","DOI":"10.3389\/fimmu.2023.1037945","volume":"14","author":"X Yu","year":"2023","unstructured":"Yu, X., Zhu, L., Wang, T. & Chen, J. Immune microenvironment of cholangiocarcinoma: biological concepts and treatment strategies. Front. Immunol. 14, 1037945 (2023). Epub 20230417. doi: 10.3389\/fimmu.2023.1037945. PubMed PMID: 37138880; PubMed Central PMCID: PMCPMC10150070.","journal-title":"Front. Immunol."},{"issue":"3","key":"25463_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jhep.2023.05.010","volume":"79","author":"JL Tomlinson","year":"2023","unstructured":"Tomlinson, J. L., Valle, J. W. & Ilyas, S. I. Immunobiology of cholangiocarcinoma. J. Hepatol. 79 (3), 867\u2013875. https:\/\/doi.org\/10.1016\/j.jhep.2023.05.010 (2023).","journal-title":"J. Hepatol."},{"issue":"Suppl 1(Suppl 1","key":"25463_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","volume":"73","author":"L Fabris","year":"2021","unstructured":"Fabris, L., Sato, K., Alpini, G. & Strazzabosco, M. The tumor microenvironment in cholangiocarcinoma progression. Hepatology 73 (Suppl 1(Suppl 1), 75\u201385 (2021). Epub 20201106. doi: 10.1002\/hep.31410. PubMed PMID: 32500550; PubMed Central PMCID: PMCPMC7714713.","journal-title":"Hepatology"},{"key":"25463_CR20","doi-asserted-by":"publisher","first-page":"1001297","DOI":"10.3389\/fimmu.2022.1001297","volume":"13","author":"W Wu","year":"2022","unstructured":"Wu, W. et al. Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer. Front. Immunol. 13, 1001297. https:\/\/doi.org\/10.3389\/fimmu.2022.1001297 (2022). Epub 20230109.","journal-title":"Front. Immunol."},{"issue":"1","key":"25463_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","volume":"15","author":"Y Tie","year":"2022","unstructured":"Tie, Y., Tang, F. & Wei, Y. Wei X-w. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J. Hematol. Oncol. 15 (1), 61. https:\/\/doi.org\/10.1186\/s13045-022-01282-8 (2022).","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"25463_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.31092","volume":"72","author":"S Job","year":"2020","unstructured":"Job, S. et al. Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma. Hepatology 72 (3), 965\u2013981. https:\/\/doi.org\/10.1002\/hep.31092 (2020). Epub 20200816.","journal-title":"Hepatology"},{"issue":"4","key":"25463_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s12072-019-09954-3","volume":"13","author":"KS Ahn","year":"2019","unstructured":"Ahn, K. S. et al. Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach. Hepatol. Int. 13 (4), 490\u2013500. https:\/\/doi.org\/10.1007\/s12072-019-09954-3 (2019). Epub 20190618.","journal-title":"Hepatol. Int."},{"issue":"19","key":"25463_CR24","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.7150\/thno.47938","volume":"10","author":"WY Cai","year":"2020","unstructured":"Cai, W. Y. et al. Identification of a tumor Microenvironment-relevant gene set-based prognostic signature and related therapy targets in gastric cancer. Theranostics 10 (19), 8633\u20138647. https:\/\/doi.org\/10.7150\/thno.47938 (2020). Epub 20200709.","journal-title":"Theranostics"},{"key":"25463_CR25","doi-asserted-by":"publisher","first-page":"1100285","DOI":"10.3389\/fmolb.2022.1100285","volume":"9","author":"Y Tang","year":"2022","unstructured":"Tang, Y., Guo, C., Chen, C. & Zhang, Y. Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma. Front. Mol. Biosci. 9, 1100285 (2022). Epub 20221216. doi: 10.3389\/fmolb.2022.1100285. PubMed PMID: 36589233; PubMed Central PMCID: PMCPMC9800843.","journal-title":"Front. Mol. Biosci."},{"key":"25463_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.gene.2018.12.043","volume":"690","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma. Gene 690, 129\u2013136. https:\/\/doi.org\/10.1016\/j.gene.2018.12.043 (2019).","journal-title":"Gene"},{"issue":"10","key":"25463_CR27","doi-asserted-by":"publisher","first-page":"e110064","DOI":"10.1371\/journal.pone.0110064","volume":"9","author":"L Li","year":"2014","unstructured":"Li, L. et al. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma. PLoS One. 9 (10), e110064. https:\/\/doi.org\/10.1371\/journal.pone.0110064 (2014). Epub 20141010.","journal-title":"PLoS One"},{"key":"25463_CR28","doi-asserted-by":"publisher","unstructured":"Shin, H. J., Gil, M. & Lee, I. S. Association of Elevated Expression Levels of COL4A1 in Stromal Cells with an Immunosuppressive Tumor Microenvironment in Low-Grade Glioma, Pancreatic Adenocarcinoma, Skin Cutaneous Melanoma, and Stomach Adenocarcinoma. J Pers Med. ;12(4). Epub 20220328. (2022). https:\/\/doi.org\/10.3390\/jpm12040534. PubMed PMID: 35455650; PubMed Central PMCID: PMCPMC9029283.","DOI":"10.3390\/jpm12040534"},{"key":"25463_CR29","doi-asserted-by":"publisher","unstructured":"Kim, H. S. et al. Tumor endothelial Cells-Associated integrin Alpha-6 as a promising biomarker for early detection and prognosis of hepatocellular carcinoma. Cancers (Basel). 15 (16). https:\/\/doi.org\/10.3390\/cancers15164156 (2023). Epub 20230817.","DOI":"10.3390\/cancers15164156"},{"key":"25463_CR30","doi-asserted-by":"publisher","unstructured":"Lin, H. et al. Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance. Cancer Cell. ;39(4):480\u2009\u2013\u200993.e6. Epub 20210128. (2021). https:\/\/doi.org\/10.1016\/j.ccell.2020.12.023. PubMed PMID: 33513345; PubMed Central PMCID: PMCPMC8044011.","DOI":"10.1016\/j.ccell.2020.12.023"},{"key":"25463_CR31","doi-asserted-by":"publisher","unstructured":"Huang, P. et al. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients. Genes (Basel). ;13(6). Epub 20220526. (2022). https:\/\/doi.org\/10.3390\/genes13060951. PubMed PMID: 35741714; PubMed Central PMCID: PMCPMC9222903.","DOI":"10.3390\/genes13060951"},{"key":"25463_CR32","doi-asserted-by":"publisher","unstructured":"Thorsson, V. et al. The Immune Landscape of Cancer. Immunity. ;48(4):812\u2009\u2013\u200930.e14. Epub 20180405. (2018). https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023. PubMed PMID: 29628290; PubMed Central PMCID: PMCPMC5982584.","DOI":"10.1016\/j.immuni.2018.03.023"},{"issue":"Suppl 2(Suppl 2","key":"25463_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1634\/theoncologist.2011-S2-04","volume":"16","author":"DS Finley","year":"2011","unstructured":"Finley, D. S., Pantuck, A. J. & Belldegrun, A. S. Tumor biology and prognostic factors in renal cell carcinoma. Oncologist 16 (Suppl 2(Suppl 2), 4\u201313. https:\/\/doi.org\/10.1634\/theoncologist.2011-S2-04 (2011). PubMed PMID: 21346035; PubMed Central PMCID: PMCPMC3868202.","journal-title":"Oncologist"},{"issue":"1","key":"25463_CR34","doi-asserted-by":"publisher","first-page":"10555","DOI":"10.1038\/s41598-019-47066-y","volume":"9","author":"J Park","year":"2019","unstructured":"Park, J. et al. Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma. Sci. Rep. 9 (1), 10555. https:\/\/doi.org\/10.1038\/s41598-019-47066-y (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"25463_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13046-020-01650-7","volume":"39","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling. J. Experimental Clin. Cancer Res. 39 (1), 148. https:\/\/doi.org\/10.1186\/s13046-020-01650-7 (2020).","journal-title":"J. Experimental Clin. Cancer Res."},{"issue":"35","key":"25463_CR36","doi-asserted-by":"publisher","first-page":"58172","DOI":"10.18632\/oncotarget.17345","volume":"8","author":"R Jin","year":"2017","unstructured":"Jin, R. et al. The highly expressed COL4A1 genes contributes to the proliferation and migration of the invasive ductal carcinomas. Oncotarget 8 (35), 58172\u201358183. https:\/\/doi.org\/10.18632\/oncotarget.17345 (2017). Epub 20170421.","journal-title":"Oncotarget"},{"issue":"4","key":"25463_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3892\/etm.2023.11875","volume":"25","author":"X Tian","year":"2023","unstructured":"Tian, X., Sun, J., Li, C. & Zhang, K. COL4A1 promotes the proliferation and migration of oral squamous cell carcinoma cells by binding to NID1. Exp. Ther. Med. 25 (4), 176. https:\/\/doi.org\/10.3892\/etm.2023.11875 (2023). Epub 20230307.","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"25463_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-016-0510-x","volume":"15","author":"DLP Brooks","year":"2016","unstructured":"Brooks, D. L. P. et al. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models. Mol. Cancer. 15 (1), 26. https:\/\/doi.org\/10.1186\/s12943-016-0510-x (2016).","journal-title":"Mol. Cancer"},{"issue":"1","key":"25463_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.yexcr.2019.03.022","volume":"379","author":"Y Wu","year":"2019","unstructured":"Wu, Y. et al. ITGA6 and RPSA synergistically promote pancreatic cancer invasion and metastasis via PI3K and MAPK signaling pathways. Exp. Cell Res. 379 (1), 30\u201347. https:\/\/doi.org\/10.1016\/j.yexcr.2019.03.022 (2019).","journal-title":"Exp. Cell Res."},{"issue":"4","key":"25463_CR40","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.3892\/ol.2019.10056","volume":"17","author":"L Wei","year":"2019","unstructured":"Wei, L., Yin, F., Chen, C. & Li, L. Expression of integrin \u03b1\u20136 is associated with multi drug resistance and prognosis in ovarian cancer. Oncol. Lett. 17 (4), 3974\u20133980. https:\/\/doi.org\/10.3892\/ol.2019.10056 (2019).","journal-title":"Oncol. Lett."},{"key":"25463_CR41","doi-asserted-by":"publisher","unstructured":"Khademi, R. et al. Regulation and Functions of \u03b16-Integrin (CD49f) in Cancer Biology. Cancers (Basel). ;15(13). Epub 20230702. (2023). https:\/\/doi.org\/10.3390\/cancers15133466. PubMed PMID: 37444576; PubMed Central PMCID: PMCPMC10341356.","DOI":"10.3390\/cancers15133466"},{"issue":"1","key":"25463_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-022-02315-3","volume":"41","author":"F Lin","year":"2022","unstructured":"Lin, F. et al. Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2\/ITGB6 signaling axis in ovarian cancer. J. Experimental Clin. Cancer Res. 41 (1), 129. https:\/\/doi.org\/10.1186\/s13046-022-02315-3 (2022).","journal-title":"J. Experimental Clin. Cancer Res."},{"issue":"7","key":"25463_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41419-023-05911-z","volume":"14","author":"A Liu","year":"2023","unstructured":"Liu, A. et al. Stanniocalcin 1 promotes lung metastasis of breast cancer by enhancing EGFR\u2013ERK\u2013S100A4 signaling. Cell Death Dis. 14 (7), 395. https:\/\/doi.org\/10.1038\/s41419-023-05911-z (2023).","journal-title":"Cell Death Dis."},{"issue":"1","key":"25463_CR44","first-page":"325","volume":"31","author":"S Tamura","year":"2011","unstructured":"Tamura, S. et al. Clinical significance of STC1 gene expression in patients with colorectal cancer. Anticancer Res. 31 (1), 325\u2013329 (2011). PubMed PMID: 21273618.","journal-title":"Anticancer Res."},{"key":"25463_CR45","doi-asserted-by":"publisher","unstructured":"Hayashi, M. et al. GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. Sci Signal. ;13(645). Epub 20200818. (2020). https:\/\/doi.org\/10.1126\/scisignal.aba0443. PubMed PMID: 32817372.","DOI":"10.1126\/scisignal.aba0443"},{"key":"25463_CR46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.canlet.2018.06.030","volume":"433","author":"L Maldonado","year":"2018","unstructured":"Maldonado, L. et al. Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1. Cancer Lett. 433, 242\u2013251. https:\/\/doi.org\/10.1016\/j.canlet.2018.06.030 (2018).","journal-title":"Cancer Lett."},{"issue":"1","key":"25463_CR47","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1053\/j.gastro.2010.10.009","volume":"140","author":"N Hiraoka","year":"2011","unstructured":"Hiraoka, N. et al. CXCL17 and ICAM2 are associated with a potential Anti-Tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology 140 (1), 310\u201321e4. https:\/\/doi.org\/10.1053\/j.gastro.2010.10.009 (2011).","journal-title":"Gastroenterology"},{"key":"25463_CR48","doi-asserted-by":"crossref","unstructured":"Qian, X. et al. COL4A1 promotes gastric cancer progression by regulating tumor Invasion, tumor microenvironment and drug sensitivity. Curr. Med. Chem. (2025). Epub 20250407. doi: 10.2174\/0109298673351943250314074632. PubMed PMID: 40197201.","DOI":"10.2174\/0109298673351943250314074632"},{"key":"25463_CR49","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.2147\/ott.S196150","volume":"12","author":"Y Yang","year":"2019","unstructured":"Yang, Y., Yin, S., Li, S., Chen, Y. & Yang, L. Stanniocalcin 1 in tumor microenvironment promotes metastasis of ovarian cancer. Onco Targets Ther. 12, 2789\u20132798. https:\/\/doi.org\/10.2147\/ott.S196150 (2019). Epub 20190411.","journal-title":"Onco Targets Ther."},{"issue":"2","key":"25463_CR50","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41416-022-02056-2","volume":"128","author":"D Jacenik","year":"2023","unstructured":"Jacenik, D., Karagiannidis, I. & Beswick, E. J. Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophils. Br. J. Cancer. 128 (2), 387\u2013397. https:\/\/doi.org\/10.1038\/s41416-022-02056-2 (2023).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"25463_CR51","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12967-022-03807-8","volume":"20","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer. J. Translational Med. 20 (1), 615. https:\/\/doi.org\/10.1186\/s12967-022-03807-8 (2022).","journal-title":"J. Translational Med."},{"key":"25463_CR52","doi-asserted-by":"publisher","unstructured":"Kronenberg, M. & Engel, I. NKT cells in the antitumor response: the \u03b2 version? J. Clin. Invest. 134(4), e177663. (2024). Epub 20240215. https:\/\/doi.org\/10.1172\/jci177663. PubMed PMID: 38357925; PubMed Central PMCID: PMCPMC10866647.","DOI":"10.1172\/jci177663"},{"issue":"1","key":"25463_CR53","doi-asserted-by":"publisher","first-page":"1929005","DOI":"10.1080\/2162402x.2021.1929005","volume":"10","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Double-edged effects of interferons on the regulation of cancer-immunity cycle. Oncoimmunology 10 (1), 1929005. https:\/\/doi.org\/10.1080\/2162402x.2021.1929005 (2021). Epub 20210630.","journal-title":"Oncoimmunology"},{"issue":"1","key":"25463_CR54","doi-asserted-by":"publisher","first-page":"2035919","DOI":"10.1080\/2162402X.2022.2035919","volume":"11","author":"B Oliviero","year":"2022","unstructured":"Oliviero, B. et al. MICA\/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma. Oncoimmunology 11 (1), 2035919 (2022). PubMed PMID: 35223192; PubMed Central PMCID: PMCPMC8865231.","journal-title":"Oncoimmunology"},{"issue":"4","key":"25463_CR55","doi-asserted-by":"publisher","first-page":"771","DOI":"10.21873\/invivo.11307","volume":"32","author":"IH Jung","year":"2018","unstructured":"Jung, I. H. et al. Vivo study of natural killer (NK) cell cytotoxicity against cholangiocarcinoma in a nude mouse model. Vivo 32 (4), 771\u2013781 (2018). PubMed PMID: 29936458; PubMed Central PMCID: PMCPMC6117784.","journal-title":"Vivo"},{"issue":"1","key":"25463_CR56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12935-022-02528-8","volume":"22","author":"V Karpisheh","year":"2022","unstructured":"Karpisheh, V. et al. The role of Th17 cells in the pathogenesis and treatment of breast cancer. Cancer Cell. Int. 22 (1), 108. https:\/\/doi.org\/10.1186\/s12935-022-02528-8 (2022). Epub 20220305.","journal-title":"Cancer Cell. Int."},{"issue":"3","key":"25463_CR57","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2010.05.007","volume":"139","author":"X Sun","year":"2010","unstructured":"Sun, X. et al. CD39\/ENTPD1 expression by CD4\u2009+\u2009Foxp3\u2009+\u2009regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 139 (3), 1030\u20131040. https:\/\/doi.org\/10.1053\/j.gastro.2010.05.007 (2010). Epub 20100625.","journal-title":"Gastroenterology"},{"issue":"3","key":"25463_CR58","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1593\/neo.101332","volume":"13","author":"L Feng","year":"2011","unstructured":"Feng, L. et al. Vascular CD39\/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Neoplasia 13 (3), 206\u2013IN2. https:\/\/doi.org\/10.1593\/neo.101332 (2011).","journal-title":"Neoplasia"},{"issue":"5","key":"25463_CR59","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3892\/ol.2020.12012","volume":"20","author":"S Liu","year":"2020","unstructured":"Liu, S., Zhang, J., Zhu, J., Jiao, D. & Liu, Z. Prognostic values of EDNRB in triple-negative breast cancer. Oncol. Lett. 20 (5), 149 (2020). Epub 20200824. doi: 10.3892\/ol.2020.12012. PubMed PMID: 32934717; PubMed Central PMCID: PMCPMC7471672.","journal-title":"Oncol. Lett."},{"key":"25463_CR60","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yexmp.2019.02.002","volume":"107","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism. Exp. Mol. Pathol. 107, 141\u2013157. https:\/\/doi.org\/10.1016\/j.yexmp.2019.02.002 (2019).","journal-title":"Exp. Mol. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25463-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25463-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25463-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:32:24Z","timestamp":1763987544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25463-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25463"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25463-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted following the guidelines and approved by the Animal Ethics Committee of The Second Affiliated Hospital of Fujian Medical University (No.194[2023]).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"41570"}}